Generic Name |
certolizumab |
Strength |
200 mg/mL |
Form | subcutaneous injection solution |
Special Authority Criteria |
Approval Period |
For the treatment of Ankylosing Spondylitis according to established criteria described in the Special Authority Request forms 5365 (Initial/Switch) and 5366 (Renewal), below. Coverage of certolizumab for the treatment of Ankylosing Spondylitis is available only when certolizumab is prescribed by a rheumatologist |
1 year |
Click on the appropriate Special Authority Form below for full criteria.